4
Changes in Ownership
Spero Therapeutics, Inc. Filed Acc 0000950170-24-011487
CEO and President sold 75,994 shares at an average $1.42 ($107,719)
- CEO and President acquired 679,501 shares (grant or award)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Shukla Sath CEO and President | 2024-02-01 | Grant or award 10b5-1 | +679,501 | 1,252,001 | D | ||
| Shukla Sath CEO and President | 2024-02-02 | Sale 10b5-1 | −30,901 | $1.37 | $42,334 | 1,221,100 | D |
| Shukla Sath CEO and President | 2024-02-05 | Sale 10b5-1 | −45,093 | $1.45 | $65,385 | 1,176,007 | D |
| Open-market sales · 75,994 sh · avg $1.42 · $107,719 | |||||||
Loading xslF345X05/ownership.xml…